Cargando…

An Integrated Research–Clinical BSL-2 Platform for a Live SARS-CoV-2 Neutralization Assay

A reliable and efficient serological test is crucial for monitoring neutralizing antibodies against SARS-CoV-2 and its variants of concern (VOCs). Here, we present an integrated research–clinical platform for a live SARS-CoV-2 neutralization assay, utilizing highly attenuated SARS-CoV-2 (Δ3678_WA1-s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Jing, Kurhade, Chaitanya, Chang, Hope C., Hu, Yanping, Meza, Jose A., Beaver, David, Trinh, Ky, Omlid, Joseph, Elghetany, Bassem, Desai, Ragini, McCaffrey, Peter, Garcia, Juan D., Shi, Pei-Yong, Ren, Ping, Xie, Xuping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536566/ https://www.ncbi.nlm.nih.gov/pubmed/37766263 http://dx.doi.org/10.3390/v15091855

Ejemplares similares

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
por: Hu, Yanping, et al.
Publicado: (2023)

Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of mRNA vaccine
por: Xie, Xuping, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine
por: Xie, Xuping, et al.
Publicado: (2022)

Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
por: Zou, Jing, et al.
Publicado: (2022)

Reverse genetic systems of SARS-CoV-2 for antiviral research
por: Kurhade, Chaitanya, et al.
Publicado: (2023)

Editorial: Diagnosis of zoonoses: Relevance of BSL3 and BSL4 facilities
por: Berger, Kavita, et al.
Publicado: (2022)

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection
por: Zou, Jing, et al.
Publicado: (2022)

Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2
por: Xia, Hongjie, et al.
Publicado: (2022)

The HCV genome domains 5BSL3.1 and 5BSL3.3 act as managers of translation
por: Romero-López, Cristina, et al.
Publicado: (2018)

Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
por: Kurhade, Chaitanya, et al.
Publicado: (2022)

Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection
por: Kurhade, Chaitanya, et al.
Publicado: (2022)

BslA-stabilized emulsion droplets with designed microstructure
por: Bromley, Keith M., et al.
Publicado: (2017)

Networking for BSL-3/4 laboratory scientist training
por: Weidmann, Manfred, et al.
Publicado: (2009)

Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages
por: Xia, Hongjie, et al.
Publicado: (2023)

BSL-3 Laboratory User Training Program at NUITM-KEMRI
por: Bundi, Martin, et al.
Publicado: (2014)

AVR2 Targets BSL Family Members, Which Act as Susceptibility Factors to Suppress Host Immunity
por: Turnbull, Dionne, et al.
Publicado: (2019)

Protocol for using negative pressure isolator systems to study BSL-2 organisms in gnotobiotic murine models
por: Pavao, Aidan, et al.
Publicado: (2022)

Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine
por: Zou, Jing, et al.
Publicado: (2023)

Validation of the Spanish version of the borderline symptom list, short form (BSL-23)
por: Soler, Joaquim, et al.
Publicado: (2013)

A phenomenological description of BslA assemblies across multiple length scales
por: Morris, Ryan J., et al.
Publicado: (2016)

Natural variations in the biofilm-associated protein BslA from the genus Bacillus
por: Morris, Ryan J., et al.
Publicado: (2017)

Psychometric properties of the French borderline symptom list, short form (BSL-23)
por: Nicastro, Rosetta, et al.
Publicado: (2016)

Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization.
por: Hu, Peirong, et al.
Publicado: (2018)

The 5BSL3.2 Functional RNA Domain Connects Distant Regions in the Hepatitis C Virus Genome
por: Romero-López, Cristina, et al.
Publicado: (2017)

SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles
por: Plescia, Caroline B., et al.
Publicado: (2020)

Characterization of the Growth and Morphology of a BSL-2 Coccidioides posadasii Strain That Persists in the Parasitic Life Cycle at Ambient CO(2)
por: Garcia, Javier A., et al.
Publicado: (2022)

Propagation of SARS-CoV-2 in a Closed Cell Culture Device: Potential GMP Compatible Production Platform for Live-Attenuated Vaccine Candidates under BSL-3 Conditions?
por: Klessing, Stephan, et al.
Publicado: (2023)

Bacillus anthracis S-layer protein BslA binds to extracellular matrix by interacting with laminin
por: Wang, Yanchun, et al.
Publicado: (2016)

Erratum to: Validation of the Spanish version of the borderline symptom list, short form (BSL-23)
por: Soler, Joaquim, et al.
Publicado: (2016)

Lateral interactions govern self-assembly of the bacterial biofilm matrix protein BslA
por: Arnaouteli, Sofia, et al.
Publicado: (2023)

Dichotomy of the BSL phosphatase signaling spatially regulates MAPK components in stomatal fate determination
por: Guo, Xiaoyu, et al.
Publicado: (2022)

BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein
por: Manangeeswaran, Mohanraj, et al.
Publicado: (2022)

Effect of equipment layout on bioaerosol temporal-spatial distribution and deposition in one BSL-3 laboratory
por: Liu, Zhijian, et al.
Publicado: (2020)

Validation and Application of a Bench Top Cell Sorter in a BSL-3 Containment Setting
por: Roberts, Lydia M, et al.
Publicado: (2020)

A proposed severity classification of borderline symptoms using the borderline symptom list (BSL-23)
por: Kleindienst, Nikolaus, et al.
Publicado: (2020)

Maintaining differential pressure gradients does not increase safety inside modern BSL-4 laboratories
por: Kurth, Andreas, et al.
Publicado: (2022)

Studying bona fide SARS-CoV-2 biology in a BSL-2 biosafety environment using a split-virus-genome system
por: Ma, Yingxin, et al.
Publicado: (2022)

Translation, validity and reliability of the British Sign Language (BSL) version of the EQ-5D-5L
por: Rogers, Katherine D., et al.
Publicado: (2016)

Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities
por: Nie, Jianhui, et al.
Publicado: (2019)

Experimental and numerical study of potential infection risks from exposure to bioaerosols in one BSL-3 laboratory
por: Liu, Zhijian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6pq8vpg344asusfcuj68hm4an7